BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?

被引：0
|
作者：
Guerrero-Ramos, F. [1 ,2 ,3 ]
机构：
[1] Hosp Univ 12 Octubre, Serv Urol, Unidad Urooncol, Madrid, Spain
[2] ROC Clin, Madrid, Spain
[3] Hosp Univ HM Sanchinarro, Madrid, Spain
来源：
ACTAS UROLOGICAS ESPANOLAS | 2023年 / 47卷 / 06期
关键词：
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; VALRUBICIN; FAILURE;
D O I：
10.1016/j.acuro.2023.01.004
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [21] BLADDER SPARING TREATMENT IN PATIENTS WITH BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: AN ANALYSIS OF LONG-TERM SURVIVAL OUTCOMES
    Tan, Wei Shen
    Grajales, Valentina
    Contieri, Roberto
    Hensley, Patrick
    Bree, Kelly
    Msaouel, Pavlos
    Guo, Charles
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2023, 209 : E410 - E410
  • [22] The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: a New Zealand perspective
    O'Regan, Toni
    Tatton, Michael
    Lyon, Maryanne
    Masters, Jonathan
    BJU INTERNATIONAL, 2015, 116 : 54 - 60
  • [23] Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
    Moussa, Mohamad
    Papatsoris, Athanasios G.
    Dellis, Athanasios
    Abou Chakra, Mohamed
    Saad, Wajih
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 965 - 983
  • [24] Impulsive control dosing BCG immunotherapy for non-muscle invasive bladder cancer
    Saadi S.
    Elmouki I.
    Hamdache A.
    International Journal of Dynamics and Control, 2015, 3 (3) : 313 - 323
  • [25] TUMOR MICROBIOME ASSOCIATED WITH BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER
    Knorr, Jacob
    Adler, Ava
    Agudelo, Jose
    Ericson, Kyle
    Murthy, Prithvi
    Campbell, Rebecca
    Bajic, Petar
    Almassi, Nima
    Weight, Christopher
    Haber, Georges-Pascal
    Miller, Aaron
    Lee, Byron
    JOURNAL OF UROLOGY, 2021, 206 : E725 - E726
  • [26] Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer
    Smaldone, M. C.
    Gingrich, J. R.
    MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 129 - 132
  • [27] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [28] Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer
    Shen, Yijun
    Peng, Liangju
    Xu, Peihang
    Wang, Yanhao
    Wang, Xiang
    Yao Xudong
    Liu, Yushan
    Ye, Ding-Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)
    Alvarez-Maestro, M.
    Guerrero-Ramos, F.
    Rodriguez-Faba, O.
    Dominguez-Escrig, J. L.
    Fernandez-Gomez, J. M.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (02): : 93 - 102
  • [30] Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer
    Fletcher, Sean A.
    Bivalacqua, Trinity J.
    Brawley, Otis W.
    Kates, Max
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e13 - 195.e18
12345